Evidence map›Paper›PMID 23760494›Full record

ArticleCancer biology & therapy2013

Dietary supplemented 2-mercaptoethanol prevents spontaneous and delays virally-induced murine mammary tumorigenesis.

Robert E Click

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robert E ClickUniversity of Minnesota; Minneapolis, MN, USA. mbclicker@msn.com
University of Minnesota System · US

Funding

CONTROL OF A COMPOSITE OF DIVERSE IMMUNE FUNCTIONSR01AI019643 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CLICK, ROBERT E · 1985 to 1986
–
NCI NIH HHS R01 CA023678NIAID NIH HHS R01AI019643
6 · The paper itself

Abstract

There seems to be little doubt that organosulfur compounds have enormous benefits for biological processes, especially those of diseases like cancer. The preliminary results herein define a cancer model in which benefits/mechanisms of multitudes of xenobiotic and nature's organosulfurs could easily be compared. Mice from three strains with a high incidence for naturally occurring tumors were treated daily with 2-mercaptoethanol (2-Me) starting at weaning. The 100% tumor incidence of undefined etiology in untreated BXSB-Yaa (+) males was completely prevented by 2-Me. In contrast, 2-Me treatment of female and male C3H.OL and C3H.OH congenic strains, did not change the 100% tumor incidence due to milk-borne retrovirus, MMTV(S), but did: (1) delay the appearance of tumors by 42%; (2) increase longevity 56%; and (3) increase longevity, post-tumor detection, 95%. The addition of these results to the increasingly impressive anti-cancer benefits of simple xenobiotic organosulfurs raise the question: Can they be adapted for use as a preventive modality for human cancer?

Indexed as

Mammary Tumor Virus, MouseAdministration, OralAnimalsAnticarcinogenic AgentsDietary SupplementsDrug Screening Assays, AntitumorFemaleMaleMammary Neoplasms, ExperimentalMercaptoethanolMiceMice, Inbred C3HMice, TransgenicRetroviridae InfectionsTreatment OutcomeTumor Virus InfectionsAnticarcinogenic AgentsMercaptoethanol2-mercaptoethanolcancer prophylaxisdietaryexperimentalgarlicMMTVmurine mammary tumorsorganosulfursretrovirus

Identifiers

PMID23760494
PMCPMC3813568
OpenAlexW1981577973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.